Galera Therapeutics (GRTX) News Today → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free GRTX Stock Alerts $0.18 0.00 (0.00%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGalera Therapeutics: Galera Adopts Limited Duration Stockholder Rights Agreementfinanznachrichten.de - May 3 at 10:57 PMGalera Adopts Limited Duration Stockholder Rights Agreementglobenewswire.com - May 3 at 7:00 AMGalera Therapeutics Seeks Strategic Alternatives Amid Financial Setbacks and Regulatory Challengesmsn.com - April 1 at 5:26 AMGalera Therapeutics: Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updatesfinanznachrichten.de - March 28 at 2:09 PMGalera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updatesglobenewswire.com - March 28 at 7:00 AMGRTX Apr 2024 0.500 callfinance.yahoo.com - March 16 at 9:07 AMGalera Therapeutics, Inc. (GRTX)nz.finance.yahoo.com - March 12 at 5:23 PMGalera Therapeutics, Inc.edition.cnn.com - February 27 at 7:25 AMGalera Therapeutics Inc (GRTX)investing.com - February 4 at 12:37 AMGalera Therapeutics Stock (NASDAQ:GRTX) Dividends: History, Yield and Datesbenzinga.com - February 4 at 12:37 AMGalera Therapeutics Insiders Lose Out As Stock Sinks To US$0.17finance.yahoo.com - January 21 at 2:16 PMLocal publicly traded stocks lag far behind national indices in 2023bizjournals.com - January 16 at 1:33 PMDow Tumbles Over 200 Points; US Trade Gap Narrows In Novembermsn.com - January 9 at 2:28 PMGalera Therapeutics (GRTX) Price Target Increased by 7.14% to 0.38msn.com - November 28 at 2:59 AMGalera Therapeutics: Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updatesfinanznachrichten.de - November 14 at 8:41 AMGalera Therapeutics: Q3 Earnings Insightsbenzinga.com - November 14 at 8:41 AMGalera Reports Third Quarter 2023 Financial Results and Recent Corporate Updatesfinance.yahoo.com - November 14 at 8:41 AMGalera Therapeutics's Earnings Outlookbenzinga.com - November 13 at 2:56 PMUS Stocks Fall; Pfizer Swings To Q3 Lossbenzinga.com - November 1 at 5:19 PMDow Gains 50 Points; Global Payments Posts Upbeat Earningsbenzinga.com - October 31 at 3:16 PMGalera Therapeutics warns of potential shutdown as it halts clinical trials and stock tanksbizjournals.com - October 31 at 3:16 PMWhy Is Cancer Focused Galera Therapeutics Stock Sinking Today?msn.com - October 31 at 3:16 PMGalera plunges after citing risks to business continuitymsn.com - October 31 at 3:16 PMGalera Therapeutics: Galera Announces Receipt of Type A Meeting Minutes and Strategic Updatefinanznachrichten.de - October 31 at 10:16 AMGalera Announces Receipt of Type A Meeting Minutes and Strategic Updatefinance.yahoo.com - October 31 at 10:16 AMmarketbeat.com - October 31 at 6:59 AMGalera Therapeutics (GRTX) Gets a Hold from H.C. Wainwrightmarkets.businessinsider.com - September 19 at 9:27 AMGalera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasemfinance.yahoo.com - September 18 at 9:49 AMGalera to Participate in the H.C. Wainwright 25th Annual Global Investment Conferencefinance.yahoo.com - September 5 at 11:57 AMCiti Sticks to Its Hold Rating for Galera Therapeutics (GRTX)markets.businessinsider.com - August 30 at 3:24 PMCitigroup Maintains Galera Therapeutics (GRTX) Neutral Recommendationnasdaq.com - August 30 at 3:24 PMExpert Ratings for Galera Therapeuticsmarkets.businessinsider.com - August 29 at 7:02 PMH.C. Wainwright downgrades Galera Therapeutics (GRTX) to a Holdmarkets.businessinsider.com - August 16 at 10:13 AMGalera Reports Second Quarter 2023 Financial Results and Recent Corporate Updatesfinance.yahoo.com - August 14 at 9:07 AMGalera cut to Underperform at BofA after FDA snub for lead assetmsn.com - August 11 at 6:55 PMWhy Is Galera Therapeutics Stock Sinking Today?msn.com - August 10 at 12:56 PMGalera shares plunge 85% on FDA rejection; workforce cut by more than halffinance.yahoo.com - August 10 at 12:55 PMGalera Therapeutics: Galera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganesefinanznachrichten.de - August 10 at 7:55 AMGalera Gets CRL From FDA For Avasopasem Manganese, To Cut 70% Jobs; Stock Down In Premarketmarkets.businessinsider.com - August 10 at 7:55 AMFDA rejects Galera's treatment for mouth sores in cancer patients, stock -83% after hoursmsn.com - August 9 at 8:14 PMGalera Receives Complete Response Letter from U.S. FDA for Avasopasem Manganesefinance.yahoo.com - August 9 at 8:14 PMGalera shares tank after US FDA declines to approve inflammation disease drugfinance.yahoo.com - August 9 at 8:14 PMmarketbeat.com - August 9 at 4:38 PMGRTX - Galera Therapeutics, Inc.uk.finance.yahoo.com - July 27 at 2:31 AMSt. Louis stocks have fallen behind major indices this yearbizjournals.com - July 17 at 5:44 PMAnalysts Are Bullish on Top Healthcare Stocks: Galera Therapeutics (GRTX), Acumen Pharmaceuticals (ABOS)markets.businessinsider.com - July 17 at 7:31 AMDespite Galera Therapeutics' Pullback, Insiders Still Gained US$102kfinance.yahoo.com - June 28 at 10:40 AMPiper Sandler Remains a Buy on Galera Therapeutics (GRTX)markets.businessinsider.com - June 6 at 10:01 AMGalera Presents Additional Chronic Kidney Disease Data from ROMAN Trial at 2023 ASCO Annual Meetingfinance.yahoo.com - June 5 at 6:57 PMGalera Announces FDA Orphan Drug Designation Granted to Rucosopasem for Pancreatic Cancerfinance.yahoo.com - May 18 at 10:13 AM Get Galera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Collapse of the Petrodollar (Ad)The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason. In answer to this issue, we have released a Special Report to the public. GRTX Media Mentions By Week GRTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRTX News Sentiment▼1.870.58▲Average Medical News Sentiment GRTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRTX Articles This Week▼11▲GRTX Articles Average Week Get Galera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ADXN News Today AEZS News Today ATHE News Today CMMB News Today GHSI News Today MTEM News Today ERNA News Today BFRI News Today NCNA News Today TRVN News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRTX) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
